tirzepatide sarasota Weight Loss Injections in Tirzepatide for Newport Beach, CA

Brand Name: Semgo

Leading up to #ASCO25, Monica Avila, MD, highlights promising research showing GLP-1 drugs may lower the risk of obesity-related cancers, especially in women with diabetes

Semaglutide typically shows measurable weight loss within 4 to 8 weeks, with most patients experiencing steady progress through weeks 12 to 16

The studies involved subjects, rather small numbers in each case, who had diabetes, non-alcoholic fatty liver disease (NAFLD), polycystic ovary syndrome (PCOS), coronary disease or had kidney transplants

Sleep disturbances affect up to 30% of people starting GLP-1 therapy

One of the largest US health insurers is ending coverage of GLP-1 weight-loss drugs for its employees but will continue covering them for people with type 2 diabetes.